Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Renishaw PLC Earnings Release 2019

Oct 18, 2018

5268_rns_2018-10-18_400c8994-c22f-4d93-9830-5130393fcc33.html

Earnings Release

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4018E

Renishaw PLC

18 October 2018

Renishaw plc

Trading update

18th October 2018

Renishaw plc, the global high-precision metrology and healthcare technology group, publishes this trading update for the three months ended 30th September 2018. It contains unaudited information that covers the first quarter and the period since.

Trading activity

# Continuing operations # First quarter

2019
# First quarter

2018
# Change
# Metrology # £147.4m # £137.1m # +8%
# Healthcare # £6.6m # £5.2m # +27%
# Total revenue # £154.0m # £142.3m # +8%
Adjusted* profit before tax #

£32.6m
#

£35.8m
#

-9%
# Statutory profit before tax # £33.5m # £36.9m # -9%

Revenue from continuing operations for the first quarter of the current financial year was £154.0m, a growth of 8% over the £142.3m for the corresponding period last year. We experienced growth for the period at constant exchange rates of 7% with growth in all regions.

In our metrology business revenue amounted to £147.4m compared to £137.1m last year, with growth at constant exchange rates of 7%. Revenue in our healthcare business was £6.6m compared with £5.2m last year, a growth of 25% at constant exchange rates.

The Adjusted* profit before tax from continuing operations for the first quarter amounted to £32.6m compared with £35.8m last year and the statutory profit before tax amounted to £33.5m (2018: £36.9m).

Over recent years, we have invested in people and infrastructure to support growth opportunities and are now well placed to benefit from these investments. We anticipate the rate of investment in additional resources will reduce in the remainder of the current financial year as we continue to monitor the Group's cost base.

Financial position

The Group balance sheet remains strong with net cash balances of £115.3m as at 30th September 2018 compared to £103.8m at 30th June 2018.

Outlook

Despite the potential impacts of Brexit and economic uncertainties in Asia the Board remains confident in the future prospects of the Group and of growth in both revenue and profit in this financial year.

The results for the half year ending 31st December 2018 will be released on 31st January 2019.

Sir David McMurtry William Lee
CBE, RDI, FRS, FREng, CEng, FIMechE Chief Executive Officer
Executive Chairman
18th October 2018
Renishaw plc
Registered office New Mills, Wotton-under-Edge, Gloucestershire, GL12 8JR
Registered number 1106260
LEI number 21380048ADXM6Z67CT18
Telephone number 01453 524524
Website www.renishaw.com

*    Adjusted profit before tax

The adjustment to statutory profit relates to the accounting treatment of certain forward currency contracts used as hedging instruments which do not qualify for hedge accounting as they do not meet the hedge effectiveness criteria set out in the International Accounting Standard IFRS9 'Financial Instruments', or the criteria set out in IAS39 'Financial Instruments: Recognition and Measurement' used in the prior year. The Board deems that the adjusted profit before tax better reflects the underlying performance of the Group. The following table reconciles statutory profit before tax to adjusted profit before tax:

£'m Q1 2019 Q1 2018
Adjusted profit before tax 32.6 35.8
Fair value gains/losses on financial instruments not eligible for hedge accounting
-     reported in revenue 1.8 0.1
-     reported in (losses)/gains from the fair value of financial instruments (0.9) 1.0
Statutory profit before tax from continuing operations 33.5 36.9

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

TSTEAKEXFLKPFFF